{"paper_id":"f5894ad7-96e7-4ede-8e3a-3c59a5301a1d","body_text":"Àڱü±±ÙÁõÀºÁַΰ¡Àӱ⿩¼º¿¡¼­¹ß»ýÇÏ´ÂÈçÇѺÎÀΰú\nÁúȯÀ¸·ÎÀÚ±ÃÀûÃâ¼úÀ»½ÃÇàÇÑÈľà8 . 8 % - 3 1 %¿¡¼­¹ß°ßµÈ\n´Ù(1, 2). ºñ±â´É¼ºÀÚ±ÃÃâÇ÷À̳ªÀڱñÙÁ¾, Àڱ󻸷Áõ½ÄÁõ\nµî°ú±¸º°ÇÒ¼öÀÖ´ÂƯÀÌÇÑÀÓ»óÁõ»óÀ̾øÀÌ°ñ¹ÝÅë, »ý¸®Åë,\nÃâÇ÷°ú´ÙµîÀǺñƯÀÌÀûÀÎÁõ»óÀ»È£¼ÒÇϹǷμúÀüÁø´ÜÀÌ\n¾î·Á¿öÀÓ»óÀûÁø´ÜÀ²Àº¾à2 . 6 - 2 6 %¿¡ºÒ°úÇÑ°ÍÀ¸·Î¾Ë·ÁÁ®\nÀÖ´Ù(3). \nÀÌ·¸°ÔÀÓ»ó¼Ò°ß¸¸À¸·Î´ÂÁø´ÜÀ̾î·Á¿ì¹Ç·Î, Àڱ󻸷Áõ\n½ÄÁõµîÀ¸·Î¿ÀÀÎÇÏ¿©¼ÒÆļúÀ»½ÃÇàÇÑÈÄ¿¡µµÁõ»óÀÇÈ£Àü\nÀ»¾òÁö¸øÇϴ°æ¿ìµµ¸¹°í, ¶ÇÇÑÀڱÿ¡¼­¹ß»ýÇϴ°¡Àå\nÈçÇѺ´º¯ÀÌÀڱñÙÁ¾°ú°¨º°ÇÔÀ¸·Î½áÀûÀýÇÑÄ¡·á¹æ¹ýÀ»¼±\nÅÃÇϴµ¥µµ¿òÀ»¹ÞÀ»¼öÀÖ´Ù. ±×¸®°íÀÚ±ÃÀûÃâ¼úÀ̺ñ±³Àû\n¾ÈÀüÇѼö¼ú¹æ¹ýÀ¸·Î¾Ë·ÁÁ®ÀÖÀ¸³ªÄ¡»çÀ²ÀÌ1 0 0 0¸í´ç¾à1 -\n2 %¿¡À̸£¹Ç·Î(4), º´º¯ÀǺÐÆ÷¹üÀ§³ª±ÙÃþħ¹ü±íÀ̸¦Á¤\nÈ®È÷ÆľÇÇÏ¿©¼ö¼úÀ̾ƴѴٸ¥Ä¡·á¹æ¹ýÀ»Àû¿ëÇÒ¼öÀÖÀ¸\n¹Ç·Î´õ¿í±×Áø´ÜÀÌÁß¿äÇÏ´Ù. \nÀÌ¿¡ÀúÀÚµéÀ»MR ¿µ»óÀ»ÅëÇÑÀڱü±±ÙÁõÀǹ߰ßÀ²À»¾Ë\n¾Æº¸°í, ÀڱñÙÃþħ¹ü¹üÀ§¿Í±íÀÌ¿¡µû¸¥¹ß°ßÀ²À»ºñ±³ÇØ\nº½À¸·Î½á, ¾ÕÀ¸·ÎÀÚ±ÃÀûÃâ¼ú¿ÜÀÇ´Ù¸¥Ä¡·á¹æ¹ýÀ»Àû¿ëÇÏ´Â\nµ¥±â¿©ÇÏ°íÀÚº»¿¬±¸¸¦½ÃÇàÇÏ¿´´Ù. \n´ë»ó°ú¹æ¹ý\n1 9 9 2³â7¿ùºÎÅÍ9 8³â7¿ù±îÁö´Ù¾çÇÑÀÌÀ¯·ÎÀÚ±ÃÀûÃâ¼úÀ»\nÅëÇØÀڱü±±ÙÁõÀ¸·ÎÈ®ÁøµÈȯÀÚÁß¼úÀü¿¡MR °Ë»ç¸¦½Ã\nÇà¹ÞÀº6 5¸íÀÇȯÀÚ¸¦´ë»óÀ¸·Î, º´¸®°á°ú¸¦¸ð¸£´Â2¸íÀÇ\n¹æ»ç¼±°úÀǻ簡ÈÄÇâÀûÀ¸·ÎMR ¿µ»óÀ»ºÐ¼®ÇÏ¿´´Ù. \nȯÀÚÀÇ¿¬·ÉºÐÆ÷´Â2 5 - 7 5¼¼(Æò±Õ4 2 . 3¼¼)¿´À¸¸ç, À̵éÀÌ\n´ëÇѹæ»ç¼±ÀÇÇÐȸÁö2 0 00;42:8 19-8 2 3\n¦¡8 1 9¦¡\nÀÚ±â°ø¸í¿µ»óÀ»ÀÌ¿ëÇÑÀڱü±±ÙÁõ¿¡¼­ÀÇ\nÀڱñÙÃþħ¹üÀǹüÀ§¿Í±íÀÌÀÇÆò°¡1\nÀ̹̰桤Á¶ÀçÈ£¡¤ÀåÀçõ¡¤¹Úº¹È¯\n¸ñÀû: MR ¿µ»óÀ»ÅëÇÑÀڱü±±ÙÁõÀǹ߰ßÀ²À»¾Ë¾Æº¸°í, ÀڱñÙÃþħ¹üÀǹüÀ§¿Í±íÀ̸¦\n¾ó¸¶³ªÁ¤È®ÇÏ°ÔÆò°¡ÇÒ¼öÀÖ´ÂÁö¸¦¾Ë¾Æº¸°íÀÚÇÏ¿´´Ù.\n´ë»ó°ú¹æ¹ý: ÀÚ±ÃÀûÃâ¼úÀ»ÅëÇغ´¸®Á¶Á÷ÇÐÀûÀ¸·ÎÈ®ÁøµÈ6 5¿¹¸¦´ë»óÀ¸·ÎMR ¿µ»óÀ»ÈÄ\nÇâÀûÀ¸·ÎºÐ¼®ÇÏ¿©Àڱü±±ÙÁõÀǹ߰ßÀ²À»¾Ë¾Æº¸¾Ò°í, ÀڱñÙÃþħ¹üÀǹüÀ§¿¡µû¶ó¹Ì¸¸\n¼º¹×±¹¼Ò¼ºÀ¸·Î, ±íÀÌ¿¡µû¶ó°íµµ, Áߵ, ¹×°æµµ·ÎºÐ·ùÇÏ¿©°¢°¢¿¡µû¸¥¹ß°ßÀ²ÀÇÂ÷\nÀ̸¦¾Ë¾Æº¸¾Ò´Ù. \n°á°ú: º´¸®ÀûÀ¸·Î±¹¼Ò¼ºÀº3 5¿¹, ¹Ì¸¸¼ºÀº3 0¿¹¿´°í, 35¿¹ÀDZ¹¼Ò¼ºÀڱü±±ÙÁõÁß1 2¿¹´Â°æ\nµµ, 14¿¹´ÂÁߵ, 9¿¹´Â°íµµÀڱü±±ÙÁõÀ̾úÀ¸¸ç, 30¿¹Àǹ̸¸¼ºÀڱü±±ÙÁõ¿¡¼­´Â2¿¹´Â\n°æµµ, 10¿¹´ÂÁߵ, 18¿¹´Â°íµµÀڱü±±ÙÁõÀ̾ú´Ù. MR ¿µ»ó¿¡¼­´ÂÀÌÁß73.8% (48¿¹)¸¦\n¹ß°ßÇÒ¼öÀÖ¾ú´Âµ¥, ±¹¼Ò¼ºÀº60.0% (21¿¹), ¹Ì¸¸¼ºÀº90.0% (27¿¹)¸¦¹ß°ßÇÒ¼öÀÖ¾ú°í, °æ\nµµ´Â42.9% (6¿¹), Áߵ´Â79.2% (19¿¹), °íµµÀڱü±±ÙÁõÀº85.2% (23¿¹)¸¦¹ß°ßÇÒ¼öÀÖ\n¾ú´Ù. MR ¿µ»ó¿¡¼­º´º¯À̹߰ߵÈȯÀÚÁßÀڱñÙÃþħ¹ü±íÀÌ¿Íħ¹ü¹üÀ§°¡¸ðµÎÀÏÄ¡ÇÏ\n´Â°æ¿ì´Â5 4 . 2 %¿´°í, ¹Ì¸¸¼º( 8 1 . 5 % )¿¡¼­±¹¼Ò¼º( 1 9 . 0 % )¿¡ºñÇØ´õ¿í³ôÀºÀÏÄ¡À²À»º¸¿´\n´Ù. ÀڱñÙÃþħ¹ü±íÀÌ¿¡°ü°è¾øÀÌħ¹ü¹üÀ§¸¸ÀÏÄ¡Çϴ°æ¿ì6 6 . 7 %¿´´Âµ¥, ¿ª½Ã¹Ì¸¸¼º\n( 9 6 . 3 % )À̱¹¼Ò¼º( 2 8 . 6 % )º¸´Ù³ôÀºÀÏÄ¡À²À»º¸¿´´Ù. ÀڱñÙÃþħ¹ü±íÀ̸¸ÀÏÄ¡Çϴ°æ¿ì\n´Â82.6% ¿´´Âµ¥, °æµµ´Â83.3%, Áߵ´Â94.7%, °íµµ´Â8 2 . 6 %·Îħ¹üÀDZíÀÌÂ÷ÀÌ¿¡µû¸¥\nÀÏÄ¡À²ÀÇÂ÷À̴¾ø¾ú´Ù(Table 3).\n°á·Ð: M RÀºÀڱü±±ÙÁõÀ»Áø´ÜÇϴµ¥À¯¿ëÇÑ°Ë»çÀ̸ç, ±¹¼Ò¼ºº¸´Ù´Â¹Ì¸¸¼º, °æµµº¸´Ù´ÂÁßµµ\n¿Í°íµµ¿¡¼­¹ß°ßÀ²ÀÌ´õ¿í³ô°í, ÀڱñÙÃþÀÇħ¹ü±íÀ̸¦ÆÇ´ÜÇϴµ¥ÀÖ¾î³ôÀºÁ¤È®µµ¸¦º¸\n¿´´Ù. ÀÌ·¯ÇÑ°á°ú´ÂÀÓ»óÁõ»ó°ú»ó°üÇѼúÀüÁø´Ü¿¡µµ¿òÀ»ÁÙ¼öÀÖÀ»°ÍÀ¸·Î»ý°¢µÇ¸ç, ÀÚ±Ã\nÀûÃâ¼úÀ»´ë½ÅÇÏ´ÂÄ¡·á¹ýÀ»Àû¿ëÇϴµ¥ÀÖ¾îÁß¿äÇÑÆǴܱâÁØÀ̵ɼöÀÖÀ»°ÍÀ¸·Î»ý°¢µÈ´Ù. \n1¿µ³²´ëÇб³ÀÇ°ú´ëÇÐÁø´Ü¹æ»ç¼±°úÇб³½Ç\nÀÌ³í¹®Àº1 9 9 9³â1 0¿ù4ÀÏÁ¢¼öÇÏ¿©2 0 0 0³â3¿ù3 0ÀÏ¿¡Ã¤ÅõǾúÀ½.\n\nÀÚ±ÃÀûÃâ¼úÀ»½ÃÇà¹ÞÀº¿øÀÎÁúȯÀºÀڱðæºÎ¾Ï( 3 3¿¹), ÀÚ\n±Ã±ÙÁ¾( 1 9¿¹), ³­¼ÒÁ¾¾ç( 7¿¹), Àڱ󻸷¾Ï( 3¿¹), Àڱ󻸷\nÁõ( 1¿¹), Àڱ󻸷Áõ½ÄÁõ( 1¿¹)¿´°í, ¿ÀÁ÷1¿¹¿¡¼­¸¸Àڱü±\n±ÙÁõÀ¸·ÎÀÚ±ÃÀûÃâÀ̽ÃÇàµÇ¾ú´Ù. \n6 5¸íÁß4 4¸í¿¡¼­´Â0.5 Tesla (Gyroscan T5, Philips, DA Best,\nNetherland) MR ±â±â¸¦, 21¸í¿¡¼­´Â1.5 Tesla (Ma-gnetom\nVision, Siemens, Erlangen, Germany) ±â±â¸¦ÀÌ¿ëÇÏ¿´´Ù. T2°­\nÁ¶¿µ»óÀǽûó¸é¿¡¼­ÀڱñÙÃþħ¹ü¹üÀ§¸¦Æò°¡ÇÏ°í, ½Ã»ó¸é\n¿¡¼­Ä§¹ü±íÀÌ°¡°¡Àå±í¾îº¸ÀÌ´ÂÁöÁ¡ÀÇÃà»ó¸éÀ»ºñ±³ÇÏ\n¿©ÀڱñÙÃþħ¹ü±íÀ̸¦Æò°¡ÇÏ¿´´Ù. \nMR ¿µ»ó¿¡¼­Àڱü±±ÙÁõÀÇÁø´Ü±âÁØÀºT2 °­Á¶¿µ»ó¿¡¼­\nÀڱñÙÃþ³»¿¡ÀÛÀº°í½ÅÈ£°­µµÀǹÝÁ¡À»Æ÷ÇÔÇÏ´ÂÀú½ÅÈ£°­\nµµÀǺ´º¯À¸·Î°üÂûµÇ°Å³ª, ÀÚ±ÃÁ¢ÇÕÃþÀǵβ²°¡7 mmÀΰæ\n¿ì¿¡Àڱü±±ÙÁõÀ¸·ÎÁø´ÜÇÏ¿´°í, °£È¤ÀڱñÙÁ¾°úÀÇ°¨º°ÀÌ\n¾î·Á¿î°æ¿ì¿¡´Âº´º¯ÀǸð¾ç°úÀ±°û¹×Á¶¿µÁõ°­ÈÄ¿µ»ó¿¡\n¼­Á¶¿µÇüŸ¦ºñ±³ÇÏ¿©Áø´ÜÇÏ¿´´Ù. \nÂü°í·Îº»¿øº´¸®Çб³½Ç¿¡¼­´ÂÀڱü±±ÙÁõÀ»ÀڱñÙÃþħ\n¹ü¹üÀ§¿Í±íÀÌ¿¡µû¶ó°¢°¢ºÐ·ùÇϴµ¥, ÀڱñÙÃþħ¹ü¹üÀ§\n¿¡µû¶ó¼­´ÂÀÚ±ÃÀÇÇÑÂʺ®¸éÀüüÀÌ»óÀ̳ªÇÑÂʺ®¸éÀÇ\n50% ÀÌ»óÀ»Ä§¹üÇÑ°æ¿ì¸¦¹Ì¸¸¼º, ÇÑÂʺ®¸éÀÇ50% ¹Ì¸¸À»\nħ¹üÇÑ°æ¿ì´Â±¹¼Ò¼ºÀ¸·ÎºÐ·ùÇÏ°í, ÀڱñÙÃþħ¹ü±íÀÌ¿¡\nµû¶ó¼­´Â±ÙÃþÀÇ1/3 ¹Ì¸¸À»Ä§¹üÇÑ°æ¿ì´Â°æµµ(mild), 1/3-\n2 / 3À»Ä§¹üÇÑ°æ¿ì´ÂÁߵ(moderate), 2/3 ÀÌ»óÀ»Ä§¹üÇÑ°æ\n¿ì´Â°íµµ( s e v e r e )·ÎºÐ·ùÇÏ°íÀÖ´Ù.\n¸ÕÀúÀڱü±±ÙÁõÀǹ߰ßÀ²À»Á¶»çÇÏ¿´°í, º´º¯À̹߰ߵÈȯ\nÀÚ( 4 8¸í)¿¡¼­´ÂÀڱñÙÃþÀÇħ¹ü¹üÀ§¿¡µû¶ó¹Ì¸¸¼º¹×±¹\n¼Ò¼ºÀ¸·Î, ħ¹ü±íÀÌ¿¡µû¶ó°æµµ, Áߵ, °íµµ·ÎºÐ·ùÇÑÈÄ\nº´¸®¼Ò°ß°úºñ±³ÇÏ¿©°¢°¢¿¡µû¸¥¹ß°ßÀ²À»¾Ë¾Æº¸¾Ò´Ù.\n°á °ú\nº´¸®ÀûÀ¸·Î±¹¼Ò¼ºÀº3 5¿¹, ¹Ì¸¸¼ºÀº3 0¿¹¿´°í, 35¿¹ÀDZ¹¼Ò\n¼ºº´º¯Áß1 2¿¹´Â°æµµ, 14¿¹´ÂÁߵ, 9¿¹´Â°íµµ¿´À¸¸ç, 30\n¿¹Àǹ̸¸¼ºº´º¯Áß2¿¹´Â°æµµ, 10¿¹´ÂÁߵ, 18¿¹´Â°íµµ\n¿´´Ù(Table 1). \nMR ¿µ»ó¿¡¼­´ÂÀÌÁß4 8¿¹( 7 3 . 8 % )¸¦¹ß°ßÇÒ¼öÀÖ¾ú´Âµ¥,\n±¹¼Ò¼ºÀº3 0¿¹Áß2 1¿¹( 6 0 . 0 % )¸¦¹ß°ßÇÒ¼öÀÖ¾ú´ø¹Ý¸é, ¹Ì\n¸¸¼ºÀº3 5¿¹Áß2 7¿¹( 9 0 . 0 % )¸¦¹ß°ßÇÒ¼öÀÖ¾ú´Ù. ÀڱñÙÃþ\nħ¹üÀDZíÀÌ¿¡µû¶ó¼­´Â°æµµ´Â1 4¿¹Áß6¿¹(42.9%), Áߵ\n´Â2 4¿¹Áß1 9¿¹(79.2%), °íµµ´Â2 7¿¹Áß2 3¿¹( 8 5 . 2 % )¸¦°¢\n°¢¹ß°ßÇÒ¼öÀÖ¾ú´Ù(Table 2). \nMR ¿µ»ó¿¡¼­º´º¯À̹߰ߵÈ4 8¿¹ÁßÀڱñÙÃþħ¹üÀǹü\nÀ§¿Í±íÀ̸¦¸ðµÎÁ¤È®ÇÏ°ÔÁø´ÜÇÑ¿¹´Â(Fig. 1) 26¿¹\n( 5 4 . 2 % )¿´°í, ¹Ì¸¸¼º¿¡¼­´Â(Fig. 2) 81.5% (22/27)ÀdzôÀºÀÏ\nÄ¡À²À»º¸Àιݸé, ±¹¼Ò¼º¿¡¼­´Â(Fig. 3) 19.0% (4/21)¿¡¼­¸¸\nº´¸®¼Ò°ß°úÀÏÄ¡ÇÏ¿´´Ù. ¹Ì¸¸¼ºº´º¯Áß°æµµ´Â100.0%, Áßµî\nµµ´Â88.9%, °íµµ´Â76.5%, ±¹¼Ò¼ºº´º¯Áß°æµµ´Â20.0%, Áßµî\nµµ´Â20.0%, °íµµ´Â1 6 . 7 %ÀÇÀÏÄ¡À²À»º¸¿´´Ù. ħ¹ü±íÀÌ¿¡°ü\n°è¾øÀÌÀڱñÙÃþħ¹üÀǹüÀ§°¡ÀÏÄ¡Çϴ°æ¿ì´Â3 2¿¹\n( 6 6 . 7 % )¿´´Âµ¥, ÀÌ¿ª½Ã¹Ì¸¸¼º¿¡¼­´Â96.3% (26/27)ÀdzôÀº\nÀÏÄ¡À²À»º¸Àιݸé, ±¹¼Ò¼º¿¡¼­´Â28.6% (6/21)Àdz·ÀºÀÏÄ¡\nÀ²À»º¸¿´´Ù. ħ¹ü¹üÀ§¿Í°ü°è¾øÀÌÀڱñÙÃþħ¹üÀDZíÀÌ°¡\nÀÏÄ¡ÇÑ°æ¿ì´Â4 2¿¹( 8 2 . 6 % )¿´´Âµ¥, °æµµ´Â83.3% (5/6), Áßµî\nµµ´Â94.7% (18/19), °íµµ´Â82.6% (19/23)·Îħ¹üÀDZíÀÌÂ÷\nÀ̹̰æ¿Ü: ÀÚ±â°ø¸í¿µ»óÀ»ÀÌ¿ëÇÑÀڱü±±ÙÁõ¿¡¼­ÀÇÀڱñÙÃþħ¹üÀǹüÀ§¿Í±íÀÌÀÇÆò°¡\n¦¡8 2 0¦¡\nTable 1. Number from Extent and Depth of Myometrial Invasion\nof Adenomyosis \nPathology Diffuse Focal \nMild 2 12 \nModerate 10 1 4\nSevere 18 9\nTotal 30 3 5\nTable 2. Detection Rate from Extent and Depth of Myometrial Invasion of Adenomyosis\nExtent of Myometrial Invasion Depth of Myometrial Invasion\nDiffuse focal Mild Modereate S e v e r e\nDetection No.* 27 21 06 19 23 \nTotal No.* 35 30 14 24 27 \nDetection rate 90.0% 60.0% 42.9% 79.2% 85.2% \nN o . * : N u m b e r\nFig. 1. Forty-seven-year old patient with diffuse and severe\na d e n o m y o s i s .\nSagittal T2-weighted image shows extensive low-signal-intensity\n(arrows) lesion in the anterior and posterior wall of the uterus.\nSeveral higher signal intensity foci are seen in the lesion and\nwhich show similar signal intensity to those of endometrium.\nPreoperative MR finding was correspond to pathologic finding\nboth in the extent and depth of myometrial invasion.\n\nÀÌ¿¡µû¸¥ÀÏÄ¡À²ÀÇÂ÷À̴¾ø¾ú´Ù(Table 3).\n°í Âû\nÀڱü±±ÙÁõÀºÁַΰ¡Àӱ⿩¼º¿¡¼­ÈçÈ÷¹ß»ýÇÏ´ÂÁúȯÀ¸\n·Î, ¿ù°æ°ú´Ù, ¿ù°æÅë, °ñ¹ÝÅëÀ̳ªÀÚ±ÃÁõ´ëµîÀÇÁõ»óÀ»µ¿¹Ý\nÇÒ¼öÀִµ¥, ¿ù°æ°ú´Ù¸¦ÀÏÀ¸Å°´Â±âÀüÀºÁ¤È®ÇϰԾ˷ÁÁ®\nÀÖÁö´Â¾ÊÁö¸¸¾Æ¸¶µµ¿ù°æ½ÃÀÚ±ÃÀÌÈ¿°úÀûÀ¸·Î¼öÃàÇÏÁö¾Ê\n¾Æ¸¹ÀºÃâÇ÷À»À¯¹ßµÇ´Â°ÍÀ¸·Î»ý°¢µÇ°íÀÖ´Ù(5). ÀÌ·¯ÇÑ\nÁõ»óµéÀº±â´É¼ºÀÚ±ÃÃâÇ÷À̳ªÀڱñÙÁ¾, Àڱ󻸷Áõ½ÄÁõµî\nÀÇ´Ù¸¥ºÎÀΰúÁúȯ¿¡ºñÇØƯÀÌÇÑÁõ»óÀ̾ƴϹǷÎÀÓ»óÀû\nÀ¸·ÎÁ¤È®ÇÏ°ÔÁø´ÜÇϱâ´Â¾î·Æ´Ù(3). ÀúÀÚµéÀÇÁõ·Ê¿¡¼­´Â\n´ëºÎºÐÀÇȯÀÚ°¡ºñ½ÁÇÑÁõ»óÀ»È£¼ÒÇÏ¿´À¸³ªºñƯÀÌÀûÀÌ¿´\nÀ¸¸ç, 1¿¹¸¦Á¦¿ÜÇѸðµç¿¹µéÀÌ´Ù¸¥Áúȯµé°úµ¿¹ÝµÇ¾îÀÖ¾ú\n±â¶§¹®¿¡ÀÓ»óÁõ»ó°úÁ÷Á¢¿¬°ü½ÃÅ°´Â°ÍÀººÒ°¡´ÉÇÏ¿´´Ù. \n6 0 - 8 0 %ÀÇȯÀÚ¿¡¼­´Ù¸¥°ñ¹ÝÁúȯ°úµ¿¹ÝµÇ¾î³ªÅ¸³ª´Â\nµ¥, ÀڱñÙÁ¾ÀÌ°¡ÀåÈçÇѵ¿¹ÝµÇ´ÂÁúȯÀ¸·Î¾à35-50%, ÀÚ\n±Ã³»¸·ÁõÀÌ6 - 2 0 %¿¡¼­µ¿¹ÝµÈ´Ù°íÇϸç, ±×¿Ü¿¡´Â¿©·¯°¡\nÁöÀڱ󻸷ÁúȯÀ̵¿¹ÝµÉ¼öÀÖ´Ù. ÁÖ·ÎÀڱ󻸷Áõ½ÄÁõ, ÀÚ\n±Ã³»¸·¾ÏµîÀÌÀÌ¿¡¼ÓÇϸç, À̴¾Ƹ¶µµ°í¿¡½ºÆ®·Î°ÕÇ÷Áõ¿¡\nÀÇÇÑ°ÍÀ¸·ÎÃßÁ¤µÈ´Ù(5). ÀڱðæºÎ¾ÏÀÇ°æ¿ìµµ±×¹ß»ý·üÀÌ\n³ôÀº°ü°è·ÎÈçÈ÷µ¿¹ÝµÇ¸çÀúÀÚµéÀÇȯÀڵ鿡¼­´Â°¡ÀåÈç\nÇѵ¿¹ÝÁúȯÀ̾ú´Ù. ÀÌ·¯ÇÑ°á°ú´ÂÀڱðæºÎ¾ÏÀǹ߻ý·ü»Ó¸¸\n¾Æ´Ï¶ó±×·ÎÀÎÇѼö¼úÀÇÁõ°¡·Î¿ì¿¬È÷¹ß°ßµÇ´ÂÀڱü±±Ù\nÁõÀ̸¹¾Ò´ø°ÍÀ¸·Î»ý°¢µÇ¸ç, ÀڱñÙÁ¾ÀÇ°æ¿ìº¸Á¸ÀûÄ¡·á\n¹ý¶ÇÇѸ¹ÀÌ»ç¿ëµÇ¹Ç·Î»ó´ëÀûÀ¸·ÎÀû°Ô¹ß°ßµÈ°ÍÀ̾ƴÒ\n±î»ý°¢µÈ´Ù. \nÀڱü±±ÙÁõÀººñÁ¤»óÀûÀ¸·ÎÀڱ󻸷¼±°ú±âÁúÀ̱ÙÃþ¿¡Á¸\nÀçÇϴ°ÍÀε¥, ÀϹÝÀûÀ¸·ÎÇ¥À缺°ú½ÉÀ缺À¸·ÎºÐ·ùÇÏ°íÀÖ\nÀ¸³ª±×Áø´Ü±âÁØÀº´Ù¼Ò¸ðÈ£ÇÏ´Ù. ÀÌ´ÂÀڱ󻸷¼±À̳ª±â\nÁúÀÌÀڱ󻸷±âÀúÃþ¿¡¼­¼öm m³»¿¡¼­´ÂÈçÈ÷Á¤»óÀûÀ¸·Î\n¹ß°ßµÇ±â¶§¹®ÀÌ´Ù. Ç¥À缺Àڱ󻸷ÁõÀºÁõ»óÀ̾øÀ»¼öµµÀÖ\n¾îÀÓ»óÀûÀ¸·ÎµµÁø´ÜÀ̾î·ÆÁö¸¸, ½ÉÀ缺ÀÇ°æ¿ì´ÂÀÓ»óÁõ»ó\n°úÀÚ±ÃÁõ´ë¸¦µ¿¹ÝÇϴ°æ¿ì°¡¸¹´Ù(6). Àڱü±±ÙÁõÀºÀÚ±Ã\n³»¸·ÁõÀÇ°æ¿ì¿Í´Â´Þ¶ó, À̼ҼºÀڱ󻸷¼±Àº¿ù°æÁֱ⿡µû\n¸¥È£¸£¸ó¿¡´ëÇѹÝÀÀ¼ºÀ̾ø¾îÁÖ±âÀûÀÎÃâÇ÷À»ÇÏÁö´Â¾Ê´Â\n´Ù°íÁÖÀåµµÀÖ´Ù(5). À̼ҼºÀڱ󻸷¼±Àº¼Ò¿ëµ¹À̸ð¾çÀ¸\n·Î´Ü´ÜÇϰԽ׿©ÀÖ´ÂÆòÈ°±Ù¼¼Æ÷·ÎµÑ·¯½Î¿©ÀÖ¾îÀÚ±â°ø¸í\n¿µ»ó¿¡¼­Á¢ÇÕÃþ°úÀ¯»çÇÑÀú½ÅÈ£°­µµ·Î°üÂûµÈ´Ù°íÇÑ´Ù(7). \nÀڱü±±ÙÁõÀÇÀÚ±â°ø¸í¿µ»ó¿¡¼­ÀÇÁø´Ü±âÁØ¿¡´ëÇؼ­´Â¸¹\n´ëÇѹæ»ç¼±ÀÇÇÐȸÁö2 0 00;42:8 19-8 2 3\n¦¡8 2 1¦¡\nTable 3. Correlation Between MR and Pathologic Findings about the Extent and Depth of Myometrial Invasion \nPathology Diffuse F o c a l\nMRI Mild Moderate Severe Mild Moderate Severe T o t a l\nMild 1 1 00 3 00 0 05\nDiffuse Moderate 0 8 03 0 08 0 1 9\nSevere 0 0 13 0 00 4 1 7\nMild 0 0 00 1 00 0 01\nFocal Moderate 0 0 00 1 02 1 04\nSevere 0 0 01 0 00 1 02\nTotal 1 9 17 5 10 6 4 8\nFig. 3.Forty-year-old patient with focal severe adenomyosis.\nAbnormal low signal intensity lesion (¦J) with multiple high\nsignal foci is seen in posterior wall of uterus which involves\nfull depth of myometrium on T2-weighted sagittal image.\nPreoperative MR diagnosis was diffuse severe adenomyosis,\nso the MR finding was not correspond to pathologic finding in\nthe evaluation of the extent of myometrial invasion.\nFig. 2. Thirty seven-year-old patient with diffuse and mild ade-\nn o m y o s i s .\nSagittal T2-weighted MR image shows diffuse, relatively regu-\nlar thickening of the junctional zone (arrow heads; maximum\nthickness, 9 mm). \nPreoperative MR finding was correspond to pathologic finding\nboth in the extent and depth of myometrial invasion.\n\nÀº¿¬±¸°¡½ÃÇàµÇ¾î¿Ô´Âµ¥, ÀڱñÙÃþ°úºñ±³ÇÏ¿©´õ³·Àº½Å\nÈ£°­µµ¸¦º¸¿©Á¢Çպοͺñ½ÁÇÑÀú½ÅÈ£°­µµ·Îº¸À̴°æ¿ì,\n12 mm±îÁö¸¦Á¤»óÀ¸·ÎÁ¤ÀÇÇÏ¿©ÆÇ´ÜÇϴ°æ¿ìµµÀÖÀ¸³ª\n(8) ÀüüÀڱñÙÃþÀǵβ²°¡10 mm¸¦³ÑÁö¾Ê´Â°æ¿ì°¡¸¹\n°í, 5mm¸¦±âÁØÀ¸·ÎÇÑ¿¬±¸¿¡¼­´Â(9) À§¾ç¼ºÀ̸¹¾ÆÀúÀÚ\nµéÀº7 mm¸¦±âÁØÀ¸·ÎÇÏ¿´°í, T2 °­Á¶¿µ»ó¿¡¼­ÀڱñÙÃþ³»\nÀÛÀº°í½ÅÈ£°­µµÀǹÝÁ¡À»Æ÷ÇÔÇÏ´ÂÀú½ÅÈ£°­µµÀǺ´º¯À¸·Î\n°üÂûµÉ°æ¿ìÀڱü±±ÙÁõÀ¸·ÎÁø´ÜÇÏ¿´´Ù(8). Àڱü±±ÙÁõ°ú\nÀڱñÙÁ¾ÀDZ¸ºÐ¿¡À־´ÂÀüÀÚÀÇ°æ¿ìÁÖÀ§±ÙÃþ°ú°æ°è\n°¡ºÒ¸íÈ®Çϸç, ÀÚ±ÃÀǸð¾çÀ»¾à°£º¯Çü½ÃÅ°´Â¹Ý¸é, ÈÄÀÚÀÇ\n°æ¿ì´ÂÁ¾±«È¿°ú¸¦³ªÅ¸³»¾îÀڱÿÜÇüÀǺ¯ÇüÀ»À¯¹ßÇϸç,\n°æ°è°¡ºñ±³ÀûºÐ¸íÇÑÁ¡À»ÀÌ¿ëÇÏ¿´´Ù( 7 ) .\n°æÁúÃÊÀ½ÆÄ¿ÍÀÚ±â°ø¸í¿µ»óÀÇÀڱü±±ÙÁõÁø´ÜÀÇÁ¤È®¼ºÀ»\nºñ±³ÇѸ¹Àº¿¬±¸¿¡¼­ÀÚ±â°ø¸í¿µ»óÀÌ´õ¿ì¼öÇÏ´Ù°íº¸°íÇÏ°í\nÀÖ°í(9), ÀÚ±ÃÁõ´ë°¡Àִ°æ¿ìÀڱü±±ÙÁõ°úÀڱñÙÁ¾ÀÇ°¨º°\n¿¡À־µµÀÚ±â°ø¸í¿µ»óÀÌ´õ¿ì¼öÇÏ´Ù°íº¸°íÇÏ¿´´Ù(7). ÀÌ\n·¸°ÔÀڱü±±ÙÁõÀÇÁø´Ü¿¡ÀÖ¾î°æÁúÃÊÀ½ÆÄ( 1 1 )¿ÍÀÚ±â°ø¸í\n¿µ»óÀÇÀ¯¿ë¼ºÀº¸¹À̾˷ÁÁ®¿ÔÀ¸³ª, Áø´Ü»Ó¾Æ´Ï¶óÄ¡·á¿¡µµ\n¿òÀ̵ɼöÀÖ´ÂÀڱü±±ÙÁõÀÇÁ¤µµ¿¡´ëÇÑÆò°¡´Â°ÅÀǾø¾ú\n´Ù. ¼úÀü°æÁúÃÊÀ½ÆÄ, ÀÚ±â°ø¸í¿µ»ó, ÀڱñÙÃþ»ý°ËÀ»ÅëÇØÁø´Ü\nÇÒ¼öÀÖ´Ù°íÇϳª, »ý°ËÀºÄ§½ÀÀûÀϻӾƴ϶óÀ§Ç輺À̵û¸£\n°í, °æÁúÃÊÀ½Æķδ¾ÆÁ÷Á¤µµÆò°¡Àǽõµ°¡¾ø¾úÀ»»Ó¾Æ´Ï¶ó\n°æµµÀÇÀڱü±±ÙÁõÀ»Áø´ÜÇϴ°ÍÀº¸Å¿ì¾î·Á¿ï°ÍÀ¸·Î»ý°¢\nµÈ´Ù. µû¶ó¼­ÀúÀÚµéÀºÀÚ±â°ø¸í¿µ»óÀ»ÀÌ¿ëÇÏ¿©ÈÄÇâÀûÀ¸·Î\nÀڱü±±ÙÁõÀÇÁø´ÜÀ²°úÁ¤µµÆò°¡ÀÇÁ¤È®¼ºÀ»¾Ë¾Æº»°ÍÀε¥,\nÀÚ±â°ø¸í¿µ»óÀ»ÀÌ¿ëÇÑÁö±Ã¼±±ÙÁõÀÇÁø´ÜÀ²Àººñ±³Àû³ô¾ÒÀ¸\n¸ç, ¹Ì¸¸¼ºÀÇ°æ¿ì°¡±¹¼Ò¼ºº¸´Ù, Áߵ¿Í°íµµÀÇ°æ¿ì°¡°æµµ\nº¸´Ù´õ³ôÀº¹ß°ßÀ²À»º¸¿´´Ù. ÀڱñÙÃþħ¹üÀÇÁ¤µµÀÇ°æ¿ì´Â\n¹Ì¸¸¼ºÀººñ±³Àû³ôÀºÀÏÄ¡À²À»º¸Àιݸé, ±¹¼Ò¼ºÀº³·ÀºÀÏÄ¡\nÀ²À»º¸¿´´Ù. MR ¿µ»ó¿¡¼­ÆÇ´ÜÇÑÀڱñÙÃþħ¹üÁ¤µµ¿Íº´¸®\n¼Ò°ßÀÇÀÏÄ¡À²ºñ±³¿¡¼­±¹¼Ò¼ºÀÇ°æ¿ìÀڱñÙÃþħ¹ü±íÀÌÀÇ\nÆò°¡´Â³ôÀºÀÏÄ¡À²À»º¸¿´À¸³ª¹Ì¸¸¼ºÀ¸·ÎÀ߸øÆǵ¶µÈ°æ¿ì\n°¡¸¹¾Ò°í, »ó´ëÀûÀ¸·Î¹Ì¸¸¼ºÀÇ°æ¿ì´Â±¹¼Ò¼ºÀ¸·Î¿ÀÀεȰæ\n¿ì´Â¾ÆÁֵ幰¾ú´Ù. À̴º´¸®Á¶Á÷°Ë»ç¿¡¼­ÀÚ±ÃÀüü¸¦ÀýÆí\nÀ¸·Î¸¸µå´Â°ÍÀ̾ƴ϶ó1 cm °£°ÝÀ¸·ÎÀÚ±ÃÀýÆíÀ»¸¸µé°í\nÃß°¡ÀûÀ¸·ÎÀ°¾ÈÀûÀ¸·Î°¡Àå±íÀÌħ¹üÇÑ°ÍÀ¸·Îº¸À̴ºκÐ\n¸¸ÀýÆíÀ¸·Î¸¸µå¹Ç·Î±¹¼Ò¼ºÀ̳ª°æµµÀÇ°æ¿ì, ÀÏÄ¡À²À̳·¾Ò\nÀ»°ÍÀ¸·Î»ý°¢µÈ´Ù. ±×¿ÜÀÌ¿¬±¸ÀÇ°æ¿ì, À̹ÌÀڱü±±ÙÁõÀÌ\n¶ó´ÂÁø´ÜÀ»¾Æ´Â»óÅ¿¡¼­ºÐ¼®ÇÑ°ÍÀ¸·Î±¹¼Ò¼ºÀ̳ª°æµµÀÇ\n°æ¿ì½ÇÁ¦Áø´Ü°úÂ÷À̸¦º¸ÀϼöµµÀÖÀ¸¸çÁ¤±ÔÀÚ±â°ø¸í¿µ\n»ó¿¡¼­´Â°£°úµÇ¾úÀ»°¡´É¼ºÀÌÁ¸ÀçÇϸç, ¼ö¼úÇÑ°æ¿ì¸¸ºÐ¼®\nÇÏ¿´À¸¹Ç·Î¼ö¼úÇÏÁö¾ÊÀº¿¹µéÀº¾Ë¼ö¾ø´ÂÇÑ°èÁ¡ÀÌÀÖ´Ù. \nÀڱü±±ÙÁõ¿¡´ëÇÑÄ¡·á¹ýÀ¸·Î´Â°æ±¸¿ëÇÇÀÓÁ¦³ªÁö¼ÓÀû\nÀÎȲüȣ¸£¸óÀ̳ªÅ×½ºÅ佺Å×·ÐÀÇÅõ¾àÀÌÅ«È¿°ú¸¦°ÅµÎÁö\n¸øÇÏ°íÀÖ°í, ¿©ÀüÈ÷ÀÚ±ÃÀûÃâ¼úÀÌ°¡À帹ÀÌÀÌ¿ëµÇ°íÀÖ´Ù\n(5). ÇÏÁö¸¸ÀÓ½ÅÀ»¿øÇϴ¿©¼ºÀÇ°æ¿ì, ƯÈ÷°¡Àӱ⿩¼º¿¡\n¼­ÀÚ±ÃÀûÃâ¼ú¿Ü¿¡´Ù¸¥Ä¡·á¹ýÀÇÇʿ伺ÀÌ´ëµÎµÇ°íÀÖ´Ù.\nMcCaus- land µî( 1 0 )ÀºÀڱ󻸷¹Ú¸®¼ú(endometrial abla-\nt i o n )À»ÀÌ¿ëÇÏ¿©ÀڱñÙÃþÀÇħ¹ü¿¡µû¸¥±×Ä¡·áÈ¿°ú¸¦ºÐ\n¼®ÇÑ°á°ú,°æµµÀÇÀڱü±±ÙÁõ¿¡¼­¾ÆÁÖ¸¸Á·½º·¯¿îÈ¿°ú¸¦¾ò\nÀ»¼öÀÖ¾ú´Ù. ÀÌ·¸°Ô¼ö¼úÀüÁ¤È®ÇÑÁø´Ü, ƯÈ÷¹Ì¸¸¼ºÀÎÁö\n±¹¼Ò¼ºÀÎÁöÀÇÆò°¡¿ÍÀڱñÙÃþħ¹üÀ»ÆÇ´ÜÇÔÀ¸·Î½áÄ¡·á¹æ\n¹ýÀÇ°áÁ¤¿¡¸¹Àºµµ¿ò¸¦ÁÙ¼öÀÖ´Ù. \n°á·ÐÀûÀ¸·ÎÀÚ±â°ø¸í¿µ»óÀºÀڱü±±ÙÁõÀǹ߰߿¡¸Å¿ìÀ¯\n¿ëÇϸ籹¼Ò¼ºº¸´Ù´Â¹Ì¸¸¼º, °æµµº¸´Ù´ÂÁßµµ¿Í°íµµ¿¡¼­¹ß\n°ßÀ²ÀÌ´õ¿í³ô´Ù. ´õ¿íÀÌM RÀ»ÅëÇÑÀڱñÙÃþÀÇħ¹üÁ¤µµ\nÆÇÁ¤¿¡¼­´Âº´¸®¼Ò°ß°úÀÏÄ¡À²À̳ô¾Æ¼úÀüÁø´Ü¿¡¸¹Àºµµ\n¿òÀ̵ɼöÀÖ°í, ºÒÇÊ¿äÇÑÀÚ±ÃÀûÃâ¼úÀ»ÁÙ¿©°¡Àӱ⿩¼ºÀÇ\nÀӽŰ¡´É¼ºÀ»Áõ°¡½ÃÅ°´Â¿ªÇÒÀ»ÇÒ¼öÀÖ´Ù. µû¶ó¼­ÀÓ»óÀû\nÀ¸·ÎÀڱü±±ÙÁõÀÌÀǽɵǰųª°æÁúÃÊÀ½ÆĵîÀ¸·ÎÁ¤È®ÇÑÁø\n´ÜÀ̵ÇÁö¾Ê´Â°æ¿ìħ½ÀÀûÀÎÀڱñÙÃþ»ý°Ëº¸´Ù´ÂÀÚ±â°ø\n¸í¿µ»óÀ»ÀÌ¿ëÇÏ¿©ÆÇ´ÜÇÔÀÌ´õ¾ÈÀüÇϸçÀ¯¿ëÇÒ°ÍÀÌ´Ù. \nÂü°í¹®Çå\n1 .McCarthy S. MR imaging of the uterus. R a d i o l o g y1 9 8 9 ; 1 7 1 : 3 2 1 -\n3 2 2\n2 .Owalabi TO, Strickler RC. Adenomyosis: a neglected diagnosis.\nObstet Gynecol1 9 7 7 ; 5 0 : 4 2 4 - 4 2 7\n3 .Benson RC, Sneeden VD. Adenomyosis: a reappraisal of sympto-\nmatology. Am J Obstet Gynecol1 9 5 8 ; 7 6 : 1 0 4 4 - 1 0 6 1\n4 .Dicker RC, Greenspan JR, Stauss LT, et al. Complications of ab-\ndominal and vaginal hysterectomy among women of reproductive\nage in the United States. Am J Obstet Gynecol1982; 144: 841-848\n5 .Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin\nNorth Am1 9 8 9 ; 1 6 : 2 2 1 - 2 3 5\n6 .Outwater EK, Siegelman ES, Deerlin VV. Adenomyosis: current\nconcepts and imaging considerations. AJR Am J Roentgenol1 9 9 8 ;\n1 7 0 : 4 3 7 - 4 4 1\n7 .Togashi K, Ozasa H, Konishi K, et al. Enlarged Uterus: differentia-\ntion between adenomyosis and leiomyoma with MR imaging.\nR a d i o l o g y1 9 8 9 ; 1 7 1 : 5 3 1 - 5 3 4\n8 .Reinhold C, McCarthy S, Bret PM, et al. Diffuse adenomyosis:\ncomparison of endovaginal US and MR imaging with histopatho-\nlogic correlation. R a d i o l o g y1 9 9 6 ; 1 9 9 : 1 5 1 - 1 5 8\n9 .Ascher SM, Arnold LL, Patt RH, et al. Adenomyosis: prospective\ncomparison of MR imaging and transvaginal sonography.\nR a d i o l o g y1 9 9 4 ; 1 9 0 : 8 0 3 - 8 0 6\n1 0 .McCausland AM, McCausland VM. Depth of endometrial penetra-\ntion in adenomyosis helps determine outcome of rollerball abla-\ntion. Am J Obstet Gynecol1 9 9 6 ; 1 7 4 : 1 7 8 6 - 1 7 9 4\n1 1 .Reinhold C, Atri M, Mehio A, et al. Diffuse uterine adenomyosis:\nmorphologic criteria and diagnostic accuracy of endovaginal\nsonography. R a d i o l o g y1 9 9 5 ; 1 9 7 : 6 0 9 - 6 1 4\nÀ̹̰æ¿Ü: ÀÚ±â°ø¸í¿µ»óÀ»ÀÌ¿ëÇÑÀڱü±±ÙÁõ¿¡¼­ÀÇÀڱñÙÃþħ¹üÀǹüÀ§¿Í±íÀÌÀÇÆò°¡\n¦¡8 2 2¦¡\n\n´ëÇѹæ»ç¼±ÀÇÇÐȸÁö2 0 00;42:8 19-8 2 3\n¦¡8 2 3¦¡\nJ Korean Radiol Soc 2000;42:8 19-8 2 3\nAddress reprint requests to : Jae Ho Cho, M.D., Department of Diagnostic Radiology, School of Medicine, Yeungnam University, \n317-1, Daemyungdong, Namgu, Taegu, 705-717, Korea.\nTel. 82-53-620-3043    Fax. 82-53-653-5484    E-mail: jhcho@medical.yeungnam.ac.kr\nAssessment of the Depth and Extent of Myometrial Invasion in \nUterine Ad e n o myosis Using MRI1\nMi Gyung Yi, M.D., Jae Ho Cho, M.D., Jay Chun Chang, M.D. Bok Hwan Park, M.D.\n1Department of Diagnostic Radiology, School of Medicine, Yeungnam University\nPurpose: To determine the detection rate of MRI in the diagnosis of adenomyosis and ascertain the accuracy\nof MRI in assessing the extent and depth of the myometrial invasion.\nMaterials and Methods: By retrospective analysis of MR images of the pelvis in 65 pathologically proven cases\nof uterine adenomyosis, we investigated the detection rate and differences of in the detection rate when this\nwas based on (a) the extent, and (b) the depth of myometrial invasion. The condition was classified as diffuse\nor focal according to the extent of invasion, and mild, moderate, or severe according to its depth.\nResults: Pathologically, there were 35 cases of focal adenomyosis (53.8%), and 30 of diffuse adenomyosis\n(46.2%). Among patients with the focal variety of this condition, 12 cases were mild, 14 were mild, 14 were\nmoderate, and nine were severe, while among those with the diffuse variety, two were mild, ten were moder-\nate and 18 were severe. A total of 48 cases (73.8%) were detected on MR images; the detection rate of focal\nadenomyosis was 60.0% (21/35) and that of diffuse adenomyosis was 90.0% (27/30). The detection rates of\nmild, moderate, and severe adenomyosis were 42.9%(6/14), 79.2%(19/24), and 85.2% (23/27), respectively.\nAmong the 48 cases detected on MR images, the pathologic and MR findings were consistent with regard to\nboth the extent and depth of myometrial invasion in 26(54.2%). For diffuse adenomyosis, the consistency rate\nwas higher than for the focal variety (81.5%, 22/27; compared with 19%, 4/21). The extent of myometrial inva-\nsion was correctly evaluated in 32 cases (66.7%); the consistency rate for the diffuse form was higher than for\nthe focal form [96.3% (26/27), compared with 28.6% (6/21)]. In 42 cases (87.5%), the depth of invasion was cor-\nrectly evaluated, though differences in this depth were not significant.\nConclusion: MR imaging was a useful imaging modality in the diagnosis of uterine adenomyosis. With regard\nto the extant of mymetrial invasion, the detection rate was higher among cases of the diffuse form than of the\nfocal form, and with regard to depth, the rate was higher among moderate and severe cases than among mild\nones. These findings may be useful for preoperative diagnosis based on clinical symptoms, and provide impor-\ntant yardstick for decisions as to whether hysterectony should be replaced by an alternative therapy.\nIndex words :Uterus, MRI\nUterus, abnormalities\nUterus, myometrium\n\n¦¡824 ¦¡\n¡¶ÀúÀ۱ǿ¡°üÇѵ¿ÀǼ­¡·\n¶ó´ÂÁ¦¸ñÀÇ³í¹®ÀÌ´ëÇѹæ»ç¼±ÀÇÇÐȸÁö¿¡Ãâ°£µÉ°æ¿ì±×ÀúÀÛ±ÇÀ»´ëÇѹæ»ç¼±ÀÇÇÐȸ¿¡ÀÌÀüÇÑ´Ù.\nÀúÀÚ´ÂÀúÀÛ±ÇÀÌ¿ÜÀǸðµç±ÇÇÑÁï, ƯÇã½ÅûÀ̳ªÇâÈÄ³í¹®À»ÀÛ¼ºÇϴµ¥À־º»³í¹®ÀÇÀϺÎȤÀº\nÀüºÎ¸¦»ç¿ëÇϴµîÀDZÇÇÑÀ»¼ÒÀ¯ÇÑ´Ù. ÀúÀڴ´ëÇѹæ»ç¼±ÀÇÇÐȸÁö·ÎºÎÅͼ­¸éÇã°¡¸¦¹ÞÀ¸¸éŸ³í¹®¿¡º»\n³í¹®ÀÇÀڷḦ»ç¿ëÇÒ¼öÀÖÀ¸¸çÀÌ°æ¿ìÀÚ·á°¡¹ßÇ¥µÈ¿ø³í¹®À»¹àÈù´Ù. º»³í¹®ÀǸðµçÀúÀڴº»³í¹®¿¡\n½ÇÁ¦ÀûÀÌ°íÁöÀûÀΰøÇåÀ»ÇÏ¿´À¸¸ç³í¹®Àdz»¿ë¿¡´ëÇÏ¿©°øÀûÀÎÃ¥ÀÓÀ»°øÀ¯ÇÑ´Ù.\nº»³í¹®Àº°ú°Å¿¡ÃâÆǵÈÀûÀ̾øÀ¸¸çÇöÀçŸÇмúÁö¿¡Á¦ÃâµÇ¾ú°Å³ªÁ¦ÃâÇÒ°èȹÀ̾ø´Ù.\nº»µ¿ÀǼ­´Â¿ø°í¿¡±â¼úµÈ¼ø¼­´ë·ÎÀüÀúÀÚÀǼ­¸íÀÌÀÖ¾î¾ßÇÔ.\n´ëÇѹæ»ç¼±ÀÇÇÐȸ¿ø°íÃÖÁ¾Á¡°ËÇ¥\n§¿ø°í1ºÎ, »çÁø1ºÎ¸¦µ¿ºÀÇÑ´Ù.\n§Çà°£¿©¹é1Çà(double space)¿¡2 1¡¿30cm (A4)¿ëÁö¿¡ÀÛ¼ºÇÑ´Ù.\n§¿ø°í¹è¿­ÀºÇѱ۰ú¿µ¹®À¸·Î±âÀçµÈÇ¥Áö, ³»Ç¥Áö, ÃÊ·Ï(Çѱ۰ú¿µ¹®), ¼­·Ð, ´ë»ó°ú¹æ¹ý, \n°á°ú, °íÂû, Âü°í¹®Çå, Ç¥, »çÁø¼³¸íÀǼøÀ¸·ÎÇÑ´Ù.\n§ÃÊ·ÏÀº¸ñÀû, ´ë»ó°ú¹æ¹ý, °á°ú, °á·ÐÀ¸·Î³ª´©¾î±â¼úÇÑ´Ù.\n§¿µ¹®ÃÊ·ÏÇÏ´Ü¿¡»öÀδܾî(Index Words)¸¦±âÀÔÇÑ´Ù.\n§ÀúÀ۱ǿ¡°üÇѵ¿ÀǼ­¿¡ÀüÀúÀÚ°¡¼­¸íÇÑ´Ù.\n§Åõ°í±ÔÁ¤³»ÀÇÀúÀÚÁ¡°Ë»çÇ×À»Á¡°ËÇÏ¿´´Ù.\nÁ¦1ÀúÀÚ/³â ¿ù ÀÏ Á¦2ÀúÀÚ Á¦3ÀúÀÚ\nÁ¦4ÀúÀÚ Á¦5ÀúÀÚ Á¦6ÀúÀÚ\n[ºÐ¾ß:                      ]","source_license":"CC0","license_restricted":false}